Avid Bioservices Inc (CDMO)

[Protector]

geocappy, selling such item would be a MATERIAL EVENT.

Mentioning the sales of IP in a PR, and given EXOSOMES have different patents, does NOT sufficiently describe the material event according SEC rules.

It is like writing a PR and saying:

PPHM/CDMO sold something to related to PS-Targeting to Oncology.

That does NOT allow shareholders to make investment decisions as they might have well sold a book on Phosphatidylserine.

Even the somewhat more explicit statement in the PR does NOT, CLEARLY NOT, allow us to know :
- WHAT IS SOLD
- WHAT IS PROFIT (if Oncology sells/licenses to YET another party at poor conditions so profits are creamed off and X% of Oncology profits are no longer X% of the profits realized to end customer, etc).

A ONE PERSON COMPANY, with NO OFFICIAL CONTACT data other the a mail address on a STRANGE DOMAIN NAME (international), the owner can put ANY prefix, hence oncology.international), with a death page Web-Site, company created just last December, no funding and initial payments in 6 monthly parts, terms disclosed 6+ months after deal, subsidiary in China, that is where PS-Targeting is NOW.

This IS SET_UP because the current BoD could in NO WAY have anticipated such a buyer UNLESS they were in on it and ACTIVELY participated in lowering the shareholders value by not ADEQUATELY do what we asked them in our letters to advertise the sell of the PS-targeting platform.

And judges have in the past established this to be a personal responsibility of BoD/CEO people that even in Delaware will not be protected by BYLAWS because it is a form of FRAUD.

AIMO.